Dror Ortho-Design, Inc. (DROR) Form S-1/A — Sep 16, 2026
Dror Ortho-Design filed an S-1/A for a firm-commitment offering of 3,636,364 shares at an assumed $4.13 per share, with estimated net proceeds of approximately $13.0 million, or approximately $15.0 million if the underwriters' 545,455-share over-allotment is exercised in full. Titan Partners is sole bookrunner, and the company will not proceed with the offering unless its Nasdaq Capital Market listing application under the symbol "DROR" is approved. The filing discloses an expected 1-for-550 reverse stock split prior to or upon effectiveness, reducing 976,997,116 pre-split shares to roughly 1,776,358 shares.
Key figures
- Cash Position
- approximately $228 thousand (as of December 31, 2025)
- Offering Price
- 4.13
- Shares Offered
- 3636364
- Net Loss2024
- $5.8 million
- Net Loss2025
- $2.5 million
- Lockup Period Days
- 180
- Last Sale Price Date
- September 15, 2026
- Special Meeting Date
- September 23, 2026
- Over Allotment Shares
- 545455
- Underwriter Warrants
- 254545
- Estimated Net Proceeds
- approximately $13.0 million, or approximately $15.0 million if over-allotment exercised in full
- Last Reported Sale Price
- 0.0074
- Bridge Debentures Tranches
- ["$300,000","$200,000","$200,000","$600,000","$200,000","$250,000","$200,000","$275,000","$275,000"]
- Prefunded Warrants Offered
- 3636364
- Reverse Split Ratio Expected
- 1-for-550
- Shares Outstanding Pre Split
- 976997116
- Shares Outstanding Post Split
- 1776358
- Reverse Split Ratio Range For Vote
- 1-for-2 to 1-for-2,000
- Shares Outstanding Post Offering
- 5412722
- Underwriter Warrant Exercise Price
- 5.1625
- Bridge Debentures Extended Maturity
- October 31, 2026
- Shares Issuable Warrants Preferred Options Pre Split
- 1744346896
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.